Apoptosis induced by beta-amyloid25-35 in acetylcholinesterase-overexpressing neuroblastoma cells

Acta Pharmacol Sin. 2003 Sep;24(9):853-8.

Abstract

Aim: To examine the relationship between apoptosis induced by beta-amyloid fragment 25-35 (A beta 25-35) and the activity of acetylcholinesterase (AChE) in AChE over-expresser--SC42 cells.

Methods: Cell survival was measured by microscopy and MTT reduction; DNA laddering was observed by electrophoresis; AChE activity was determined by spectrophotometry.

Results: A beta 25-35 1 micromol/L exposure for 24-48 h caused a significant decrease in cell viability, along with changes in morphology and DNA fragmentation. AChE activity was affected in an inverse manner, increasing gradually to a level that was 1.7-fold higher than control at the 48-h time point. No change in the cytotoxicity of A beta 25-35 was observed when the increased AChE activities were effectively inhibited by huperzine A throughout the 48-h exposure period.

Conclusion: Although A beta 25-35 can induce apoptosis in SC42 cells and simultaneously increase AChE activity, the capacity of AChE to hydrolyze acetylcholine is not involved in this apoptosis model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism*
  • Alkaloids
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Apoptosis / drug effects*
  • Cell Survival / drug effects
  • Cholinesterase Inhibitors / pharmacology
  • DNA Fragmentation
  • Mice
  • Neuroblastoma / pathology
  • Neuroprotective Agents / pharmacology
  • Peptide Fragments / pharmacology*
  • Sesquiterpenes / pharmacology
  • Tumor Cells, Cultured

Substances

  • Alkaloids
  • Amyloid beta-Peptides
  • Cholinesterase Inhibitors
  • Neuroprotective Agents
  • Peptide Fragments
  • Sesquiterpenes
  • amyloid beta-protein (25-35)
  • huperzine A
  • Acetylcholinesterase